CD8+ T-cell immune escape by SARS-CoV-2 variants of concern
Despite the efficacy of antiviral drug repositioning, convalescent plasma (CP), and the currently available vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the worldwide coronavirus disease 2019 (COVID-19) pandemic is still challenging because of the ongoing emergence...
Main Authors: | Arnaud John Kombe Kombe, Fleury Augustin Nsole Biteghe, Zélia Nelly Ndoutoume, Tengchuan Jin |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.962079/full |
Similar Items
-
Editorial: Host-microbe interaction in SARS-CoV-2 infection: mechanism and intervention
by: Arnaud John Kombe Kombe, et al.
Published: (2023-04-01) -
Advances in Etiopathological Role and Control of HPV in Cervical Cancer Oncogenesis
by: Arnaud John Kombe Kombe, et al.
Published: (2023-10-01) -
Immune Evasion by the Highly Mutated SARS-CoV-2 Omicron Variant
by: Mengist HM, et al.
Published: (2022-07-01) -
Protective CD8+ T cell responses against the pre-erythrocytic stages of malaria parasites: an overview
by: J Oliveira-Ferreira, et al.
Published: (2001-02-01) -
The diverse effects of transforming growth factor-β and SMAD signaling pathways during the CTL response
by: Karthik Chandiran, et al.
Published: (2023-06-01)